Paper40856423
The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression.
Yang A and 2 others. Cancer Med, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. Papers, record 40856423. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40856423
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins c-mdm2 | Major topic |
| Esophageal Neoplasms | Major topic |
| Esophageal Squamous Cell Carcinoma | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Disease Progression | |
| Cell Proliferation | |
| Cell Line, Tumor | |
| Apoptosis | |
| Female | |
| Male | |
| Cell Movement | |
| Mice, Nude | |
| Gene Expression Regulation, Neoplastic | |
| Tumor Suppressor Protein p53 | |
| Middle Aged | |
| Cyclin-Dependent Kinase Inhibitor p21 |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32287078 | A Scoring Method for Immunohistochemical Staining on Ki67. | Appl Immunohistochem Mol Morphol | 2021 | https://conductscience.org/library/papers/32287078 | PubMed |
| 2 | 26550276 | MDM2 T309G polymorphism and esophageal cancer risk: a meta-analysis. | Int J Clin Exp Med | 2015 | https://conductscience.org/library/papers/26550276 | PubMed |
| 3 | 34900524 | Advances and challenges in the treatment of esophageal cancer. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/34900524 | PubMed |
| 4 | 34050758 | GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34050758 | PubMed |
| 5 | 32913098 | The GTEx Consortium atlas of genetic regulatory effects across human tissues. | Science | 2020 | https://conductscience.org/library/papers/32913098 | PubMed |
| 6 | 35392233 | PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/35392233 | PubMed |
| 7 | 16251348 | The homologous putative GTPases Grn1p from fission yeast and the human GNL3L are required for growth and play a role in processing of nucleolar pre-rRNA. | Mol Biol Cell | 2006 | https://conductscience.org/library/papers/16251348 | PubMed |
| 8 | 27764577 | Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation. | Cell Cycle | 2016 | https://conductscience.org/library/papers/27764577 | PubMed |
| 9 | 37393256 | Genomic and transcriptional characterization of early esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | https://conductscience.org/library/papers/37393256 | PubMed |
| 10 | 21132010 | GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest. | Oncogene | 2011 | https://conductscience.org/library/papers/21132010 | PubMed |
| 11 | 24610951 | Nucleostemin and GNL3L exercise distinct functions in genome protection and ribosome synthesis, respectively. | J Cell Sci | 2014 | https://conductscience.org/library/papers/24610951 | PubMed |
| 12 | 34733320 | Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme. | Front Genet | 2021 | https://conductscience.org/library/papers/34733320 | PubMed |
| 13 | 33932560 | Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | https://conductscience.org/library/papers/33932560 | PubMed |
| 14 | 35361964 | Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/35361964 | PubMed |
| 15 | 26796597 | MDM2 gene amplification in esophageal carcinoma. | Oncol Rep | 2016 | https://conductscience.org/library/papers/26796597 | PubMed |
| 16 | 38617454 | MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/38617454 | PubMed |
| 17 | 16978205 | Quantification of immunohistochemistry--issues concerning methods, utility and semiquantitative assessment II. | Histopathology | 2006 | https://conductscience.org/library/papers/16978205 | PubMed |
| 18 | 17034816 | A novel lysine-rich domain and GTP binding motifs regulate the nucleolar retention of human guanine nucleotide binding protein, GNL3L. | J Mol Biol | 2006 | https://conductscience.org/library/papers/17034816 | PubMed |
| 19 | 19487455 | GNL3L stabilizes the TRF1 complex and promotes mitotic transition. | J Cell Biol | 2009 | https://conductscience.org/library/papers/19487455 | PubMed |
| 20 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42591837 | Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanism. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42591837 | PubMed |
| 42444932 | GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444932 | PubMed |
| 40856423 | The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. | Cancer Med | 2025 | https://conductscience.org/library/papers/40856423 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GNL3L | 54552 | PubTator's text mining | https://conductscience.org/library/genes/54552 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40856423
GET https://conductscience.org/api/papers/v1/40856423/references?page=2